Are sex disparities in COVID-19 a predictable outcome of failing men's health provision?
Tharu TharakanChristopher C KhooAleksander GiwercmanChanna N JayasenaNikolaos SofikitisAlessia d'ArmaSuks MinhasPublished in: Nature reviews. Urology (2021)
The COVID-19 pandemic, caused by the SARS-CoV-2 coronavirus, has taken a catastrophic toll on society, health-care systems and the economy. Notably, COVID-19 has been shown to be associated with a higher mortality rate in men than in women. This disparity is likely to be a consequence of a failure to invest in men's health, as it has also been established that men have a lower life expectancy and poorer outcomes from non-communicable diseases than women. A variety of biological, social and economic factors have contributed to the sex disparities in mortality from COVID-19. A streamlined men's health programme - with the urologist as the gatekeeper of men's health - is needed to help prevent future tragedies of this nature.
Keyphrases
- polycystic ovary syndrome
- sars cov
- healthcare
- coronavirus disease
- public health
- middle aged
- mental health
- respiratory syndrome coronavirus
- health information
- health promotion
- cardiovascular events
- pregnant women
- randomized controlled trial
- metabolic syndrome
- clinical trial
- current status
- adipose tissue
- study protocol